Ventavia Research Group
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tran, Van ANn
ABNCoV2-03, NCT05329220 / 2021-005504-36: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Completed
3
4205
Europe, US
ABNCoV2, Comirnaty
Bavarian Nordic
COVID-19 Disease
03/23
10/23
RSV OA=ADJ=012, NCT06534892: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Recruiting
3
12000
Europe, Canada, Japan, US, RoW
RSVPreF3 OA vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
09/26
09/26
SWEET, NCT06214221: Using Signos mHealth Platform in Adults for Weight Management

Active, not recruiting
N/A
380
US
Signos System, Standard Lifestyle Education
Signos Inc, Lindus Health, Inc.
Overweight and Obesity, Metabolic Syndrome, Weight Loss
12/24
04/26
NCT05969756: Early Treatments for Preventing Occlusal Caries Lesions

Active, not recruiting
N/A
114
RoW
Fluoride varnish, 3M™ Clinpro™ White Varnish, Conventional etch and rinse sealant, 3M™ Clinpro™ Sealant, Self-etch sealant, S-PRG filler-containing resin sealant, Beautisealant
Hue University of Medicine and Pharmacy
Caries; Initial, Occlusal Caries, Caries,Dental
10/24
10/24
Vasquez, Kathleen
ABNCoV2-03, NCT05329220 / 2021-005504-36: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Completed
3
4205
Europe, US
ABNCoV2, Comirnaty
Bavarian Nordic
COVID-19 Disease
03/23
10/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tran, Van ANn
ABNCoV2-03, NCT05329220 / 2021-005504-36: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Completed
3
4205
Europe, US
ABNCoV2, Comirnaty
Bavarian Nordic
COVID-19 Disease
03/23
10/23
RSV OA=ADJ=012, NCT06534892: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Recruiting
3
12000
Europe, Canada, Japan, US, RoW
RSVPreF3 OA vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
09/26
09/26
SWEET, NCT06214221: Using Signos mHealth Platform in Adults for Weight Management

Active, not recruiting
N/A
380
US
Signos System, Standard Lifestyle Education
Signos Inc, Lindus Health, Inc.
Overweight and Obesity, Metabolic Syndrome, Weight Loss
12/24
04/26
NCT05969756: Early Treatments for Preventing Occlusal Caries Lesions

Active, not recruiting
N/A
114
RoW
Fluoride varnish, 3M™ Clinpro™ White Varnish, Conventional etch and rinse sealant, 3M™ Clinpro™ Sealant, Self-etch sealant, S-PRG filler-containing resin sealant, Beautisealant
Hue University of Medicine and Pharmacy
Caries; Initial, Occlusal Caries, Caries,Dental
10/24
10/24
Vasquez, Kathleen
ABNCoV2-03, NCT05329220 / 2021-005504-36: ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2

Completed
3
4205
Europe, US
ABNCoV2, Comirnaty
Bavarian Nordic
COVID-19 Disease
03/23
10/23

Download Options